Document is current
Any future updates will be listed below
-
Authors
Tokita, Akio
Nunokawa, Hanako
Liu, Keibun
Iwamoto, Yuta
Sonoo, Tomohiro
Hara, Konan
Nakajima, Mikio
Fukaguchi, Kiyomitsu
Takeda, Takanori
Sanip, Amirudin
Juzar, Dafsah A.
Gurjeet Singh, a/l Harvendhar Singh
Condro, Lukito
Tobing, Monalisa
Abu Hasan, Muhammad Abdus-Syakur bin
Nik Abdul Rahman, Nik Hisamuddin
Mahisa, Orizanov
Aviesena Zairinal, Ramdinal
Ramli, Mohd Khairulizwan bin
Mohd Nor, Mohd Afiq
Goto, Tadahiro
Zakaria, Mohd Idzwan bin
-
Funding
Funding for this research was provided by:
2022 Healthcare Industry International Development Promotion Project, Ministry of Technology and Innovation and Medical Excellence Japan
Project for Promotion of International Development of Medical Technology, National Center for Global health and Medicine and Ministry of Health Labor and Welfare
Asia DX Promotion Project in ASEAN, Ministry of Technology and Innovation and The Japan External Trade Organization (JAA220803002)
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 27 August 2024
First Online: 3 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: Tomohiro Sonoo is the CEO of TXP Medical and holds related stock shares. Konan Hara received funding, study materials, medical writing support, and article processing charges from TXP Medical Co. Ltd. He also received consulting fees, honoraria for educational events, and holds stock options in the company. Dafsah Arifa Juzar serves as Secretary General of the Indonesian Heart Society from 2019 to 2022 and as Vice Secretary General from 2022 to 2025. The remaining authors report no conflicts of interest.
